Extension of Partnership Leverages Automation to Support Central Pharmacy Operations and Patient Care Initiatives
Council Member Brandi Gabbard of District 2 to Join Company Leadership for May 1st Dedication Ceremony
Omnicell, Inc. (NASDAQ: OMCL) announces results for its first quarter ended March 31, 2019.
New Solutions Will Help Optimize Workflows and Enhance Patient Safety
Solutions Leverage Automation to Optimize Hospital Workflows, Improve Financial Performance and Enhance Patient Safety
Automation for Sterile Compounding and Patient Care Areas Support Improved Clinical Care
Company to Feature Fully Digitized, Autonomous Pharmacy Vision in Booth #1208
Company to Showcase Advanced Automation to Improve Medication Management
New Solutions to Help Improve Efficiency and Safety in Patient Care Areas and Create More Autonomous Process for In-house Sterile Compounding in Pharmacy
Technology, Intelligence, and Expert Services Showcased in Booth #2071 Designed to Address Rising Medication Management Costs
Omnicell, Inc. (NASDAQ: OMCL) announces results for its fiscal year and fourth quarter ended December 31, 2018.
Company Also Sweeps Category Leader Designations for Central Pharmacy Automation Hardware
Latest Automated Solutions Help Enhance Quality and Safety for Medication Management and In-house Sterile Compounding in Pharmacy and Patient Care Areas
New Technologies Target Zero Error, Fully Automated Medication Management
Automated Solutions Help Enhance Quality and Safety for Medication Management and In-house Sterile Compounding
Technology Evolution Affirms Omnicell’s Mission to Enable Pharmacists to Perform at the Top of their License